Company Information
CIN
Status
Date of Incorporation
07 September 1995
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
28 September 2023
Paid Up Capital
101,270,530
Authorised Capital
150,000,000
Directors
Amit Varma
Director/Designated Partner
over 2 years ago
over 2 years ago
Mehul Madhusudan Shah
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Nilesh Navinchandra Maniar
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Rajiv Gulati
Director
about 5 years ago
about 5 years ago
Renuka Ramnath
Nominee Director
about 9 years ago
about 9 years ago
Himanshu Mahendra Gandhi
Director/Designated Partner
almost 24 years ago
almost 24 years ago
Madhusudan Nyalchand Shah
Director/Designated Partner
about 30 years ago
about 30 years ago
Patents
The present invention provides compositions for treating hypertrophic scars. Specifically, the invention includes compositions for treating hypertrophic scar. The invention also includes a method for treating hypertrophic scar and administering Guanidine hydrochloride for treating hypertrophic scar.
...
TOPICAL COMPOSITION FOR INFECTION
ABSTRACT
The present invention relates to a topical pharmaceutical composition comprising a combination of Fusidic acid or pharmaceutically acceptable salt, ester, prodrug thereof, and Framycetin or pharmaceutically acceptable salt, ester, prodrug thereof and optionally Silver for...
ORAL DENTIFRICE COMPOSITION
ABSTRACT
The present invention provides a pharmaceutical formulation comprising of fluoride compounds in the form of oral composition. More particularly, the present invention provides a stable oral formulation comprising of fluoride ion containing compound for prevention and/or treatme...
ABSTRACT OF THE INVENTION
TOPICAL COMPOSITION
The present invention relates to a topical pharmaceutical composition comprising Apremilast loaded Nanostructured Lipid Carriers or pharmaceutically acceptable salt, ester, pro drug thereof, for the treatment of psoriasis and other skin diseases.
...
ABSTRACT OF THE INVENTION
HEAD LICE COMPOSITION
The present invention relates to a composition and method for treating and/ or preventing a subject having ectoparasites. Specifically, the invention relates to a formulation for treating and/ or preventing head lice by using topical composition containing fatty ...
Registered Trademarks
[Class : 42] Scientific And Technological Services; Medical And Pharmaceutical Research, Research And Development For Cure Of Diseases, Consultancy And Advisory Services Relating To Testing And Manufacture Of Pharmaceutical Products.
[Class : 10] Surgical, Medical, Dental And Veterinary Apparatus And Instruments, Artificial Limbs, Eyes And Teeth; Orthopaedic Articles; Suture Materials.[Class : 44] Medical Care, Hygienic And Beauty Care Services Given By Persons Or Establishments To Human Beings And Animals.
[Class : 42] Scientific And Technological Services; Medical And Pharmaceutical Research, Research And Development For Cure Of Diseases, Consultancy And Advisory Services Relating To Testing And Manufacture Of Pharmaceutical Products.
View +11 more Brands for Encube Ethicals Private Limited.
Charges
22 March 2019
Citi Bank N.a.
62 Crore
31 July 2009
Hdfc Bank Limited
86 Crore
20 March 2009
Janakalyan Sahakari Bank Limited
50 Lak
20 March 2009
Janakalyan Sahakari Bank Limited
66 Lak
03 February 2007
Icici Bank Limited
2 Crore
10 October 2005
Icici Bank Ltd.
2 Crore
31 July 2009
Hdfc Bank Limited
0
22 March 2019
Citi Bank N.a.
0
10 October 2005
Icici Bank Ltd.
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
03 February 2007
Icici Bank Limited
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
31 July 2009
Hdfc Bank Limited
0
22 March 2019
Citi Bank N.a.
0
10 October 2005
Icici Bank Ltd.
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
03 February 2007
Icici Bank Limited
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
31 July 2009
Hdfc Bank Limited
0
22 March 2019
Citi Bank N.a.
0
10 October 2005
Icici Bank Ltd.
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
03 February 2007
Icici Bank Limited
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
31 July 2009
Hdfc Bank Limited
0
22 March 2019
Citi Bank N.a.
0
10 October 2005
Icici Bank Ltd.
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
03 February 2007
Icici Bank Limited
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
31 July 2009
Hdfc Bank Limited
0
22 March 2019
Citi Bank N.a.
0
10 October 2005
Icici Bank Ltd.
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
03 February 2007
Icici Bank Limited
0
20 March 2009
Janakalyan Sahakari Bank Limited
0
Documents
Form DPT-3-04032021_signed
Form DIR-12-14112020_signed
Evidence of cessation;-12112020
Form MGT-7-12112020_signed
Copy of MGT-8-11112020
List of share holders, debenture holders;-11112020
Form MSME FORM I-10112020_signed
Form DIR-12-09102020_signed
Optional Attachment-(1)-07102020
Instrument(s) of creation or modification of charge;-01102020
Form CHG-1-01102020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20201001
Form MGT-14-19082020-signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-29072020
Optional Attachment-(3)-29072020
Optional Attachment-(1)-29072020
Altered memorandum of association-29072020
Optional Attachment-(2)-29072020
Optional Attachment-(2)-12052020
Form DIR-12-12052020_signed
Optional Attachment-(1)-12052020
Interest in other entities;-12052020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-12052020
Form DPT-3-03022020-signed
Form MGT-7-05012020_signed
Copy of MGT-8-30122019
List of share holders, debenture holders;-30122019
Form AOC-4(XBRL)-07122019_signed
Optional Attachment-(1)-29112019
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-29112019
